Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Angiotensin 2 for the Prevention of Kidney Injury After Liver Transplant
NCT04592744Phase 4Active, not recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Apr 2022
- Primary completion
- Dec 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Angiotensin II in acute kidney injury (AKI), sponsored by University of California, Los Angeles. Started Apr 2022; status: active, not recruiting.
02
Drugs
Angiotensin II
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04592744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592744.